W Han, H Pan, Y Chen,
J Sun, Y Wang, J Li, W Ge… - PloS one, 2011 - journals.plos.org
Epidermal growth factor receptor tyrosine kinase inhibitors gefitinib and erlotinib have been
widely used in patients with non-small-cell lung cancer. Unfortunately, the efficacy of EGFR …